Position in BHVN
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$4,679,060
+$4,380,956 QoQ
Shares Held
314,453
+792.4% QoQ
Ownership
0.208%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#61
of 294 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BHVN Over Time
Shares Held
Position Value (USD)
Derivatives in BHVN
reported options exposure · as of Mar 31, 2025CallValue
$0
CallShares
0
PutValue
$1,202,000
PutShares
50,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026CITIGROUP INC holds $2,077,377,990 across 384 Biotechnology names. BHVN ranks #69 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
706,968 | $351,172,214 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
346,637 | $216,142,034 | |
| 3 | MRNA |
Moderna, Inc.
|
2,165,414 | $151,643,941 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
2,225,190 | $78,749,472 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
227,786 | $68,570,419 | |
| 6 | INCY |
Incyte Corp
|
586,431 | $66,477,817 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
864,101 | $64,358,241 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
247,052 | $46,267,897 |
All Filings in BHVN
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,679,060 | 314,453 | Shares | Defined | 2026-08-03 | |
| 2026-03-31 | $298,104 | 35,237 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $328,819 | 29,125 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $224,579 | 14,962 | Shares | Defined | 2025-11-10 | |
| 2025-06-30 | $3,254,202 | 230,631 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $6,514,740 | 270,996 | Shares | Defined | 2025-05-12 | |
| 2025-03-31 | $1,202,000 | 50,000 | Put | Defined | 2025-05-12 | |
| 2024-12-31 | $7,236,934 | 193,760 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $5,991,651 | 119,905 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $1,843,237 | 53,104 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $9,051,191 | 165,500 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $4,911,427 | 114,753 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $3,821,049 | 146,907 | Shares | Defined | 2023-12-06 | |
| 2023-06-30 | $1,775,674 | 74,234 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $3,938,928 | 288,355 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $2,255,178 | 162,477 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $862,157 | 139,997 | Shares | Defined | 2022-11-10 | |
| No filing history on record for this holder in this stock. | ||||||